Introduction
Hepatocellular carcinoma (HCC) has become the most common leading cause of cancer-associated mortality globally. 1 Although in recent years there are mounting progresses in clinical treatment for HCC, the 5-year survival rate of HCC patients is still poor and exceeds 600,000 people dying of HCC each year. 2 Uncontrolled tumor metastasis, frequent intrahepatic propagation and extrahepatic progression are the main causes for the poor prognosis of HCC. Identification of the prognostic predictors and key molecular mechanisms that influence the metastasis and progression of HCC will be meaningful.
In the human genome, ~2% of transcripts can be translated into proteins, whereas 98% of transcripts are non-coding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). 3 The lncRNAs are .200 nucleotides in length and unable to be translated into proteins. Increasing evidence has demonstrated that submit your manuscript | www.dovepress.com
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Xu et al lncRNAs can function as oncogenes or tumor suppressors, 4, 5 which could regulate downstream genes at different levels, including chromatin modification and transcriptional and posttranscriptional processing. [6] [7] [8] Colon cancer-associated transcript 2 (CCAT2), a novel lncRNA mapping to 8q24 genomic region, was first discovered by Ling et al. 9 They showed that CCAT2 was highly overexpressed in microsatellite-stable colorectal cancer and promoted tumor growth, metastasis and chromosomal instability. Overexpression of CCAT2 can also promote the metastasis and invasion of breast, lung and stomach cancer cells and influence the prognosis of breast and stomach cancers. [10] [11] [12] However, the biological function and clinical significance of CCAT2 in HCC remain unknown.
Therefore, we performed a study to investigate the role of CCAT2 in HCC and its potential prognostic value. We found that the expression of CCAT2 was upregulated in HCC cell lines and tissues, and high CCAT2 expression was associated with advanced tumor-node-metastasis (TNM) stage, frequent vessel invasion and poor patient prognosis. Decreased CCAT2 expression in HCC cells significantly suppressed cell migration and invasion. Furthermore, we also showed that alteration of CCAT2 expression can influence E-cadherin, vimentin and snail2 levels, indicating that CCAT2 affected HCC progression partly through snail2-induced epithelial-mesenchymal transition (EMT). 
Materials and methods clinical specimens
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Results
ccaT2 expression is upregulated in human hcc cell lines and tissues and correlated with prognosis of hcc patients
As shown in Figure 1A , CCAT2 level in three cancer cell lines (HepG2, SMMC772 and MHCC97H) was significantly higher than that of normal liver cell line (MIHA). Among all 96 pairs of HCC patients, CCAT2 expression level was significantly upregulated in 64% (61/96) of tumors compared with adjacent normal tissues (P,0.01) ( Figure 1B ).
To assess the correlation of CCAT2 expression with clinicopathological characteristics, all cases were divided into low (n=48) or high (n=48) CCAT2 expression groups based on the median of CCAT2 expression level. As shown in Table 2 , the high CCAT2 expression group showed higher TNM stage (P=0.041) and more frequent vessel invasion (P=0.026) than the low CCAT2 expression group. Besides, CCAT2 was significantly overexpressed in patients with alcoholism history (P=0.041). However, there was no significant correlation between CCAT2 expression and other clinicopathological parameters such as sex, age, tumor size and smoking (P.0.05). Figure 1C is a Kaplan-Meier survival analysis depicting the relationship between CCAT2 expression and the prognosis of HCC. The mean survival time for low CCAT2 expression groups was 47.433±2.188 months, whereas that for high CCAT2 expression groups was only 31.267±3.196 months (P,0.01 by log-rank test).
Furthermore, a Cox proportional hazards model analysis was used to assess the prognostic parameters in patients with HCC. Multivariate analysis showed that, after TNM stage, vessel invasion, sex, age, tumor size and alcoholism were adjusted, CCAT2 expression was independently associated with OS, with a hazard ratio (HR) of 1.849 (95% confidence interval [95% CI], 1.064-3.213; P=0.029; Table 3 ).
ccaT2 promotes hcc cell migration and invasion in vitro
Migration and invasion ability strongly correlate with cancer progression and metastasis. To investigate whether CCAT2 had a functional role in facilitating HCC cell metastasis, we performed wound-healing assay and Transwell assay. CCAT2 expression was downregulated by siRNAmediated gene silencing in both HepG2 and MHCC97H cells. The knockdown of CCAT2 expression in the cells University Cancer Institute (Shanghai, China). The HCC cell lines were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum (FBS) at 37°C in an atmosphere containing 5% CO 2 . HepG2 and MHCC97H cells were cultured in six-well plates and transfected with siRNA or negative control using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. The siRNA specifically targeting CCAT2 (siRNA-CCAT2) was synthesized (Invitrogen). The siRNA sequences are shown in Table 1 .
Monolayer wound-healing assay
Cell migration was analyzed using a wound-healing assay. Treated HepG2 and MHCC97H cells were plated in six-well plates containing 10% FBS medium. Once the cells reached 90% density, the monolayer was scratched and then cultured in fresh medium for 48 h. Mitomycin C was applied to inhibit the cell division. The migration distances of the cells were measured from the images (five fields) that were obtained at the indicated time point.
Transwell invasion assay
The invasion ability of HCC cell was performed using 24-well Transwells (8 mm pore size; Corning Life Sciences) coated with 1 mg/mL Matrigel (BD Sciences). The cells were seeded in the upper chamber of the wells in 100 μL FBSfree medium, and 500 μL of 20% FBS medium was added to the lower chambers. Following incubation for 24 h, the cells remaining on the upper membrane were removed with cotton wool. Cells that had invaded through the membrane were stained with methanol and 0.1% crystal violet and photographed with a phase-contrast inverted microscope (Olympus, Tokyo, Japan). The cells from at least five random microscopic fields (×40) were counted. 
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Xu et al was demonstrated by qRT-PCR ( Figure 2A ). As shown in Figure 2 , low CCAT2 expression in HepG2 and MHCC97H cells, which were transfected with siRNA-CCAT2, exhibited a significantly lower scratch closure rate than that in control cells ( Figure 2B ). Moreover, compared with the control cells, low CCAT2 expression in HCC cells also showed markedly repressed invasion ability ( Figure 2C ). These findings indicate that CCAT2 expression may play a pivotal role in the migration and invasion of HCC cells.
ccaT2 promotes hcc cell eMT
EMT plays crucial roles during cancer initiation and progression, especially in increasing invasion and migration ability of cancer cells. 13, 14 To further investigate the possible mechanism by which CCAT2 promotes HCC progression, the expression levels of EMT-related markers such as vimentin, E-cadherin and snail2 were detected by qRT-PCR in HCC tissues. As expected, the Pearson's correlation analysis showed that the expression of CCAT2 in HCC lesions was positively correlated with vimentin (r=0.587, P,0.001) and snail2 (r=0.494, P,0.001) and negatively related to E-cadherin (r=−0.233, P=0.022). Next, we transfected CCAT2 siRNA into HepG2 cells and analyzed its effects on the expression of vimentin, snail2 and E-cadherin. We found that the expression levels of vimentin and snail2 were significantly reduced in cells treated with siRNA-CCAT2. However, the expression of E-cadherin was increased after inhibition of CCAT2 (Figure 3 ). These data support our hypothesis that CCAT2 influences HCC progression by regulating snail2-induced EMT.
Discussion
Increasing evidence links dysregulation of lncRNAs to diverse human diseases, including HCC. [15] [16] [17] [18] In this study, we found that CCAT2 was upregulated in HCC tissues and cell lines, compared with adjacent normal tissues and normal liver 
1195
role of long non-coding rna ccaT2 in hepatocellular carcinoma cell line. High CCAT2 expression was significantly correlated with aggressive tumor characteristics (higher tumor stage and vessel invasion) and poor prognosis. Moreover, multivariate analyses showed that CCAT2 expression was an independent prognostic factor for HCC patients. These findings support the concept that the CCAT2 expression level could serve as a prognostic biomarker for HCC. CCAT2 expression is exhibited in different manners in various types of tumors. Qiu et al 11 reported that CCAT2 was a lung adenocarcinoma-specific lncRNA and not correlated with sex, smoking, TNM stage, tumor size or lymph node metastasis. However, Wang et al 12 found that high CCAT2 expression was associated with higher incidence of lymph node metastasis and distance metastasis and predicted poor prognosis in gastric cancer. In addition, Redis et al 10 revealed that CCAT2 overexpression decreases the sensitivity of breast cancer cells to 5-fluorouracil (5-FU). Interestingly, CCAT2 expression in breast cancer was inversely correlated with nodal status, having the highest expression in lymph nodenegative disease. Therefore, CCAT2 may exert cancer-typedependent effects. Further studies are definitely required to examine the role of CCAT2 in different human tumors.
Recent studies indicate that lncRNAs play an important role in tumor metastasis. Knockdown of lncRNA SPRY4-IT1 inhibited the migration and invasion of colorectal cancer cells and induced cell cycle arrest. 19 The lncRNA FTX could inhibit HCC cell growth and metastasis both in vitro and in vivo. 20 CCAT2 has also been shown to promote proliferation and invasion in breast, 10 lung 11 and cervical cancer cells. 21 We then determined the effect of CCAT2 in HCC cells. We found that downregulated expression of CCAT2 inhibited cell migration and invasion, in line with the findings of Zhou et al. 22 However, compared with the study performed by Zhou et al, our study has two strengths: first, our study revealed that the expression of CCAT2 in HCC tissue is an independent prognostic factor for HCC; second, we found that, besides regulating migration, CCAT2 was involved in the pathogenesis of HCC by regulating EMT.
There are various mechanisms of CCAT2 being involved in the pathogenesis of cancer. Previous data showed that upregulation of CCAT2 might promote the proliferation and metastasis of cancer cells through enhancing the WNT pathway.
9,23 CCAT2 could physically interact with TCF7L2, by which the expressions of miR-17-5p, miR-20a and MYC are regulated in colon cancer. 9 To date, the detailed molecular mechanism through which CCAT2 contributes to HCC progression is still unclear. Recent studies have revealed that some lncRNAs can regulate tumor cell metastasis by affecting the EMT process in HCC. 20, 24, 25 Therefore, we further analyzed the relationship between CCAT2 and EMT in HCC. Hallmarks of EMT are the aberrant expression of E-cadherin, vimentin and the transcription factor, snail. We found that CCAT2 expression was positively correlated with vimentin and snail2 and negatively related to E-cadherin in HCC tissues, basically supporting our hypothesis that CCAT2 was involved in the pathogenesis of HCC via regulating EMT. Then, we examined the expression levels of snail2, E-cadherin and vimentin following inhibition of CCAT2 in HCC cells. We found that depletion of CCAT2 inhibited snail2 and vimentin expression and promoted E-cadherin expression, indicating that CCAT2 mediated promoting effects on HCC cell metastasis possibly by affecting the Snail2-induced EMT. EMT is implicated in the promotion of tumor cell invasion and metastasis. Therefore, as an important regulator of EMT, CCAT2 could be a suitable candidate for intervention in the treatment of cancer, serving as a drug target. Drugs that could regulate the expression of CCAT2 have clinical application prospects.
Conclusion
We found that CCAT2 was upregulated in HCC tissues and cells and served as a negative prognostic factor in HCC patients. More importantly, we primarily confirmed
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